News

Pfizer and Valneva Initiate Phase 3 Study of Lyme Disease Vaccine Candidate VLA15

Pfizer and Valneva announced the initiation of a Phase 3 clinical study, Vaccine Against Lyme for Outdoor Recreationists (VALOR) (NCT05477524), to…

Read more

How the genome is packed into chromosomes that can be faithfully moved during cell division

Researchers from the Gerlich Group at IMBA discovered a molecular mechanism that confers special physical properties to chromosomes in dividing human…

Read more

Receptor FIBCD1 newly identified in neuro-developmental disorders

A multidisciplinary study led by Vanja Nagy (LBI-RUD/CeMM/Medical University of Vienna) and Josef Penninger (UBC/IMBA) characterized a novel gene,…

Read more

The ecology and evolution of giant viruses: ERC Starting Grant for Anouk Willemsen

Anouk Willemsen, virologist at the Centre for Microbiology and Environmental Systems Science (CMESS), receives a highly endowed ERC Starting Grant for…

Read more

On standby: how the developing embryo guards against viral infection

Stem cells intrinsically express genes normally associated with the innate immune system, but in the absence of external stimuli such as viral…

Read more

The axolotl, a new model to improve the healing of broken bones

Although bone fractures rank high amongst the most frequent traumatic injuries, treating and healing large fractures remains a medical challenge: bone…

Read more

The beginning of life: The early embryo is in the driver's seat

One often thinks that the early embryo is fragile and needs support. However, at the earliest stages of development, it has the power to feed the…

Read more

Johannes Zuber elected EMBO Member

IMP senior scientist Johannes Zuber is one of only 58 newly elected members of the European Molecular Biology Organization (EMBO). The rare…

Read more

CEBINA publishes data demonstrating the anti-histamine azelastine inhibits infection by major variants of SARS-CoV-2

CEBINA announced the publication of research results demonstrating that the commonly used anti-histamine, azelastine, is a potent inhibitor of major…

Read more

“The idea is to connect people” - Manuela Baccarini elected Vice-Rector of the University of Vienna

Congratulations to Max Perutz Labs faculty member Manuela Baccarini, who has been elected new Vice-Rector for Research and International Affairs of…

Read more

Exhibition about Max Perutz draws over 5.000 visitors

Although he was awarded the Nobel Prize for his research on hemoglobin, Max Perutz is hardly known to a broader public in Austria. The exhibition and…

Read more

“Cherish the beginning” - Interview with new group leader Stephanie Ellis

Stephanie Ellis studied in Canada and obtained a PhD from the University of British Columbia after which she did post-doctoral work with Elaine Fuchs…

Read more